1 / 15

Subprojekt 2.3

Subprojekt 2.3. Prevention of Chronification in Patients with Depression and Somatoform Disorders Winfried Rief Philipps University, Marburg. Final Presentation, 06/10/03. E. Rauh A. Nanke W. Rief. N. Baltruschat S. Pausch E. Geissner M. Fichter. Study centers. Marburg.

verne
Télécharger la présentation

Subprojekt 2.3

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Subprojekt 2.3 Prevention of Chronification in Patients with Depression and Somatoform Disorders Winfried Rief Philipps University, Marburg Final Presentation, 06/10/03

  2. E. Rauh A. Nanke W. Rief N. Baltruschat S. Pausch E. Geissner M. Fichter Study centers Marburg Prien/Chiemsee

  3. Subprojekt 2.3 • The aims of the study were: • Analysis of predictors of outcome in patients with unexplained physical symptoms (SFD) and comorbid depression in Primary Care • Development of a brief intervention which is feasible with Primary Care needs • Evaluation of this intervention • Development of Primary Care networks Final Presentation, 06/10/03

  4. Design Aquisition of 200 patients in GP offices Subprojekt 2.3 Initial assessment Randomization Brief Intervention N = 100 Standard Medical Care N = 100 4 weeks later: 2nd assessment 6 months later: 3rd assessment Final Presentation, 06/10/03

  5. Start 4 weeks later 6 months later Prien Intervention 70 57 56 Control 17 12 10 Marburg Intervention 74 61 60 Control 66 62 56 Total 227 192 (85%) 182 (80%) Subprojekt 2.3 Completers Final Presentation, 06/10/03

  6. 77,7 % female; Mean age: 48 years no. of doctor visits (last 6 months): 16 no. of doctor visits without psychiatrists/psychotherapists (last 6 months): 14 BDI 16.0 no. of somatoform symptoms (Interview): 11 Time since onset of unexplained physical symptoms (first symptoms): 10 years Sample Characteristics Subprojekt 2.3 Final Presentation, 06/10/03

  7. Consumer Satisfaction:Patient ratings of intervention (n = 106) - „confirmed mostly/ completely“ -

  8. Hypochondriasis WI (all data; interaction p<0.01)

  9. Somatization SCL (all data; interaction p<0.02)

  10. General Psychopathology SCL (all data; interaction p<0.05)

  11. Somatization SCL (only Marburg data; interaction p<0.02)

  12. Doctor Visits (non-psychiatrists; only Marburg data; p<0.09)

  13. Linear regression analysis (difference scores;T1-T3, criterium: SOMS) Somatization SOMS (T1); β = 0.70; p<.001 Depression BDI (T1); β = -.42; p<.001 Hypochondriasis WI (T1); β = -.25; p<.006 (Psychological illness attributions; β = .15; p<.10) Prediction of Improvement Subprojekt 2.3 Final Presentation, 06/10/03

  14. Analysis of specific aspects of health care use (c.f., detailed interview on investigations, treatments, pharmaceutics etc.) Short-term versus long-term effects (Preliminary analyses: Improvements develop slowly) Responders versus non-responders; development of indication rules Cross-sectional analyses (e.g., >100 blood samples for genetic and other tests) Problem: Sample with persisting symptoms; high user; severely disabled Next Steps Subprojekt 2.3 Final Presentation, 06/10/03

  15. Significant improvements of participants of the one-session intervention This intervention could become an important tool to improve the ineffective health care use of these patients For a broader, long-lasting effect, it would be necessary to -> train GPs in the use of our minimal intervention -> define ways for compensation of GPs doing this intervention (e.g., „Modellprojekt“ of the health care insurances) Conclusions Subprojekt 2.3 Final Presentation, 06/10/03

More Related